Aprogen Medicines Inc. (007460.KS) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Aprogen Medicines Inc.
—
Aprogen Medicines Inc. is led by CEO Jaeseob Kim, employs 311 people, headquartered in Seongnam-si, KR, publicly traded since 2005.
Aprogen Medicines Inc. (007460.KS) stock trades at $1920.00 with a market capitalization of $43.15B. The stock is valued at price-to-sales of 0.31. Over the past 52 weeks the stock has ranged between $0.00 and $14062.97, and currently trades 86.3% below its 52-week high.
On profitability, Aprogen Medicines Inc. generates a return on equity (ROE) of -30.36% (negative, reflecting a net loss), an operating margin of -75.71%, a net profit margin of -60.14%.
The balance sheet shows a debt-to-equity ratio of 0.44 (debt below half of shareholders' equity), a current ratio of 0.84.
007460.KS has an average daily trading volume of 317,719 shares, a beta of 0.09 (historically less volatile than the overall market), 0.02B shares outstanding.
Official website: www.aprogen.com
Aprogen Medicines Inc. (007460.KS) — frequently asked questions
What is Aprogen Medicines Inc. (007460.KS) stock price today?
Aprogen Medicines Inc. (007460.KS) is currently trading at $1920.00, up 0.37% today.
What is 007460.KS return on equity (ROE)?
Aprogen Medicines Inc.'s return on equity (ROE) is -30.36%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Aprogen Medicines Inc.'s market cap?
Aprogen Medicines Inc. has a market capitalization of $43.15B.
Does 007460.KS pay a dividend?
Aprogen Medicines Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 007460.KS carry?
Aprogen Medicines Inc. has a debt-to-equity ratio of 0.44. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 007460.KS's profit margin?
Aprogen Medicines Inc. reports a net profit margin of -60.14% — the share of revenue left after every cost, including tax and interest.
What sector is 007460.KS in?
Aprogen Medicines Inc. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 007460.KS listed on?
Aprogen Medicines Inc. trades on KSC under the ticker 007460.KS.
What is 007460.KS's 52-week range?
Over the last year Aprogen Medicines Inc. has traded between $0.00 and $14062.97.
Related — Stocks
Popular Stocks
Screens 007460.KS currently matches
On the figures above, Aprogen Medicines Inc. passes the filters for 5 of our ready-made screens, among them Large Cap Stocks, Stocks Over $500, Debt to Equity Below 1 Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.